SCHEDULE: Renaissance Tech Discloses 4.27% Stake in Generation Bio

Renaissance Technologies LLC and its parent company have reported a 4.27% beneficial ownership stake in Generation Bio Co. as of December 31, 2025.

Summary

• Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Generation Bio Co.
• The reporting persons collectively beneficially own 287,614 shares of Generation Bio Co. Common Stock, $0.0001 Par Value.
• This ownership represents 4.27% of the class of securities.
• Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation hold sole voting power and sole dispositive power over all 287,614 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Generation Bio Co.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as moderately positive. While the stake is below 5%, the continued presence of a highly respected quantitative fund like Renaissance Technologies as a beneficial owner suggests ongoing interest and potential long-term value in Generation Bio Co.

Positives

• A prominent quantitative hedge fund, Renaissance Technologies, maintains a beneficial ownership stake, which can be interpreted as a signal of continued interest in Generation Bio Co.
• The ownership is explicitly stated as passive, indicating no intent to influence or change the control of the issuer.

Negatives

• The reported ownership percentage of 4.27% is below the 5% threshold, indicating a reduction from a previous filing or a voluntary disclosure below the initial trigger point for a Schedule 13G.

Risks

• No specific risks related to Generation Bio Co. are mentioned in this beneficial ownership report.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that institutional ownership disclosures, such as this Schedule 13G, provide transparency into significant holdings by major investment firms. For a company like Generation Bio Co., which operates in the biotechnology sector, the continued involvement of a sophisticated quantitative fund like Renaissance Technologies can be viewed by the market as a validation of its long-term potential, even if the stake is now below 5%.

Stakeholder Impact

• Shareholders: May view the continued institutional ownership by Renaissance Technologies as a positive signal, potentially influencing investor confidence.

Key Dates

Keywords

Generation Bio Co., Renaissance Technologies, Schedule 13G, beneficial ownership, institutional ownership, common stock, biotechnology